Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
Public ClinicalTrials.gov record NCT07890415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pragmatic Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) (AI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn whether a computer-based support tool called DEXI (Dermoscopy EXplainable Intelligence) can help dermatologists decide whether a lesion may be melanoma, a serious type of skin cancer. DEXI uses artificial intelligence, or AI, which means computer technology that looks for patterns in images and information. DEXI works within a software program called the DermaGraphix Visualizer, which displays and organizes skin and lesion images. The goal of this study is to see whether DEXI can help doctors find melanoma and reduce biopsies that may not be needed.
Study identification
- NCT ID
- NCT07890415
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 14,000 participants
Conditions and interventions
Conditions
- Malignant Melanoma of Skin
- Other and Unspecified Malignant Neoplasm of Skin
- Melanoma in Situ
- Carcinoma in Situ of Skin
- Hemangioma
- Melanocytic Nevi
- Other Benign Neoplasms of Skin
- Neoplasm of Uncertain Behavior of Skin
- Neoplasm of Uncertain Behavior, Unspecified
- Neoplasm of Unspecified Behavior of Bone, Soft Tissue, and Skin
- Nevus, Non-Neoplastic
- Skin Changes Due to Chronic Exposure to Nonionizing Radiation
- Other Specified Follicular Disorders
- Other Melanin Hyperpigmentation
- Seborrheic Keratosis
- Congenital Non-Neoplastic Naevus
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2026 (Actual)
- Primary completion
- Oct 15, 2029 (Estimated)
- Completion
- Oct 15, 2029 (Estimated)
- Last update posted
- Oct 22, 2026
2026 – 2029
United States locations
- U.S. sites
- 8
- U.S. states
- 3
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University (Data Collection Only) | Stanford | California | 94305 | Not yet recruiting |
| Memorial Sloan Kettering at Basking Ridge (All protocol activities) | Basking Ridge | New Jersey | 07920 | Recruiting |
| Memorial Sloan Kettering Monmouth (Consent only) | Middletown | New Jersey | 07748 | Recruiting |
| Memorial Sloan Kettering Bergen (Consent Only) | Montvale | New Jersey | 07645 | Recruiting |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) | Commack | New York | 11725 | Recruiting |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | New York | 10604 | Recruiting |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York | New York | 10065 | Recruiting |
| Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) | Uniondale | New York | 11553 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07890415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07890415 live on ClinicalTrials.gov.